Driven by rapid advancements in chemical synthesis and biotechnology, peptides have become essential intermediates and active ingredients across research, materials science, and formulation development. However, as target peptide structures grow increasingly complex and requirements for specific sequence configurations rise, many chemical companies face significant challenges when pursuing in-house synthesis—including high technical barriers, substantial capital expenditure, and extended development timelines. As a result, outsourcing peptide synthesis to specialized custom peptide manufacturing facilities has emerged as a mainstream industry trend.